Luckys Pharma Lab Private Limited

Flownaze Nasal Spray is a combination of Fluticasone and Azelastine, formulated to provide comprehensive relief from allergic rhinitis and nasal inflammation. Fluticasone is a corticosteroid that reduces inflammation, swelling, and irritation in the nasal passages by inhibiting the release of substances that cause allergic reactions. This helps in alleviating symptoms like nasal congestion, sneezing, and itchy or runny nose.Azelastine is an antihistamine that works by blocking histamine receptors, reducing the allergic response that triggers symptoms like sneezing and itching. Together, Fluticasone and Azelastine offer a dual-action treatment, addressing both the inflammatory and allergic components of conditions like seasonal allergies, perennial allergic rhinitis, and non-allergic rhinitis.Flownaze Nasal Spray provides fast, effective, and long-lasting relief, making it ideal for individuals suffering from persistent nasal symptoms. Its targeted delivery ensures that both active ingredients work directly where the inflammation and allergies occur, promoting easier breathing and improved comfort throughout the day.

Introduction:

Medine 4 Tablet is a medication used to treat a diverse range of medical conditions, including severe allergic conditions, asthma, rheumatic disorders, skin and eye disorders, and systemic lupus erythematosus (SLE). It functions by inhibiting the release of substances that cause inflammation, thereby providing relief from various inflammatory conditions.

Uses:

Medine 4 Tablet is indicated for the treatment of:

• Severe allergic conditions
• Asthma
• Rheumatic disorders
• Skin and eye disorders
• Systemic lupus erythematosus (SLE)

Mechanism of Action:

Medine 4 Tablet works by preventing the release of inflammatory substances, thereby alleviating symptoms associated with various inflammatory conditions.

Dosage and Administration:

• Take Medine 4 Tablet with food to prevent the occurrence of an upset stomach.
• The dosage and duration of treatment will be determined by your healthcare provider based on the specific condition being treated.
• Always adhere to the prescribed dosage. Do not take a larger dose or use it more frequently than prescribed.
• Continue taking the medication regularly, even if you feel well. Some conditions may worsen if treatment is discontinued prematurely.

Precautions and Warnings:

• Inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking before starting Medine 4 Tablet.
• Pregnant or breastfeeding women should consult their doctor before using this medication.
• Avoid consuming alcohol while taking Medine 4 Tablet, as it may increase the risk of side effects.

Fluticasone Propionate I.P. 250 mcg + Salmeterol I.P. 25 mcg, sold under the brand name FLOMETROL 250, is a combination medication used primarily for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). Fluticasone Propionate, a synthetic corticosteroid, works by reducing inflammation in the airways, thereby decreasing the frequency and severity of asthma attacks or COPD exacerbations. Salmeterol, a long-acting beta agonist (LABA), functions as a bronchodilator, relaxing the muscles in the airways and facilitating easier breathing. This combination medication is typically prescribed for patients who require both an inhaled corticosteroid and a long-acting bronchodilator to effectively control their respiratory symptoms. FLOMETROL 250 is administered via an inhaler device, allowing for convenient and precise dosing. It's crucial for patients to adhere to their prescribed dosage regimen and to consult their healthcare provider if they experience any worsening of symptoms or adverse effects. Regular use of FLOMETROL 250, as directed by a healthcare professional, can help maintain optimal asthma or COPD control and improve quality of life for affected individuals.

Lucky Pharma Lab Pvt Ltd takes pride in offering Pharma Franchise opportunities in inhalers across India. With a commitment to enhancing respiratory health nationwide, we extend our PCD (Propaganda Cum Distribution) services to provide access to high-quality inhalers to communities throughout the country. Through our extensive network and robust distribution channels, we ensure that essential inhaler medications reach patients in need, regardless of their location. Our focus on innovation, quality, and affordability underscores our dedication to improving respiratory care and quality of life for individuals across India. Partner with Lucky Pharma Lab Pvt Ltd to make a meaningful difference in respiratory healthcare delivery and join us in our mission to promote better health outcomes for all.

Lucky Pharma Lab Pvt Ltd takes pride in offering Pharma Franchise opportunities in inhalers across India. With a commitment to enhancing respiratory health nationwide, we extend our PCD (Propaganda Cum Distribution) services to provide access to high-quality inhalers to communities throughout the country. Through our extensive network and robust distribution channels, we ensure that essential inhaler medications reach patients in need, regardless of their location. Our focus on innovation, quality, and affordability underscores our dedication to improving respiratory care and quality of life for individuals across India. Partner with Lucky Pharma Lab Pvt Ltd to make a meaningful difference in respiratory healthcare delivery and join us in our mission to promote better health outcomes for all.

Budeflo 400 Keyhaler combines the therapeutic benefits of formoterol fumarate and budesonide in rotacaps designed for inhalation, providing a comprehensive approach to managing asthma and chronic obstructive pulmonary disease (COPD). Formoterol fumarate, a long-acting beta agonist (LABA), acts to relax the smooth muscles of the airways, facilitating easier breathing and improving lung function. Budesonide, a corticosteroid, complements this action by reducing inflammation in the airways, thereby preventing asthma attacks and COPD exacerbations. The Keyhaler device ensures precise dosing and efficient delivery directly to the lungs, optimizing the therapeutic effects while minimizing systemic side effects. Budeflo 200 Keyhaler offers patients a reliable treatment option to control symptoms, improve lung function, and enhance overall respiratory health.

Leval 0.63 mg Respules is a formulation containing levosalbutamol, a selective beta-2 adrenergic agonist used for the management of bronchospasm associated with conditions like asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol, the active enantiomer of salbutamol, specifically targets beta-2 receptors in the lungs, leading to relaxation of the smooth muscles in the airways. This action results in rapid bronchodilation, making it easier to breathe and providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Leval 0.63 mg Respules are designed for inhalation using a nebulizer, which converts the medication into a fine mist that can be easily inhaled into the lungs. This delivery method ensures efficient absorption of levosalbutamol directly into the airways, where it acts quickly to alleviate acute symptoms or prevent bronchospasm triggered by exercise or environmental factors.

Leval 1.25 mg Respule is a respiratory solution containing levosalbutamol, a selective beta-2 adrenergic agonist used primarily for the management of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol is the active enantiomer of salbutamol, which specifically targets beta-2 receptors in the lungs. By stimulating these receptors, levosalbutamol relaxes the smooth muscles of the airways, leading to rapid bronchodilation and easing symptoms such as wheezing, shortness of breath, and chest tightness.

Administered via inhalation with a nebulizer, Leval 1.25 mg Respule delivers the medication as a fine mist directly into the lungs, ensuring efficient absorption and quick onset of action. This method is particularly beneficial for patients who may have difficulty using traditional inhalers, including young children, the elderly, or those experiencing severe bronchospasm.

Leval 1.25 mg Respule is typically used as needed to relieve acute bronchospasm or as part of a maintenance regimen to manage chronic respiratory conditions. Its rapid action helps to alleviate sudden episodes of breathing difficulties, making it an essential medication for individuals with asthma or COPD.

Budecide 0.5 is a brand that contains Budesonide 0.5 mg in a respule formulation. Budesonide is a potent corticosteroid that effectively reduces inflammation in the lungs. This medication is primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD), as well as other respiratory conditions that require anti-inflammatory treatment. By alleviating inflammation, Budecide 0.5 helps to improve breathing and control symptoms associated with these conditions. The respule formulation allows for easy administration through nebulization, making it suitable for patients who may have difficulty using inhalers or other delivery methods. It is particularly beneficial for those with severe or persistent respiratory conditions where inflammation plays a key role in symptom exacerbation. Regular use of Budecide 0.5 can help to prevent asthma attacks and improve overall lung function, contributing to a better quality of life for patients. The dosage and administration of Budecide 0.5 should be as prescribed by a healthcare professional, tailored to the specific needs of the patient, taking into account the severity of the condition, age, and response to treatment. It is important to follow the prescribed regimen and not to discontinue use abruptly, as doing so may lead to a worsening of symptoms. Patients should be advised on the proper use of the nebulizer to ensure the medication is delivered effectively to the lungs. Regular follow-ups with a healthcare provider are essential to monitor the patient’s response to treatment and make any necessary adjustments to the therapy.

Budeflo 200 keyhaler combines the therapeutic benefits of Budesonide and Formoterol in a convenient rotacap format. Each rotacap delivers a precise dose of Budesonide (200 mcg) to reduce inflammation in the airways, coupled with Formoterol (6 mcg) for effective bronchodilation, helping to manage symptoms of asthma and chronic obstructive pulmonary disease (COPD). This combination therapy is designed to provide long-lasting relief and improve respiratory function, offering patients a reliable treatment option for respiratory conditions.

Pirfenidone 200 mg, branded as My Fybro-200, is an anti-fibrotic medication used primarily in the treatment of idiopathic pulmonary fibrosis (IPF). It helps to slow down disease progression by reducing lung scarring and inflammation. The typical dosage involves a gradual increase to minimize side effects, which can include gastrointestinal issues, fatigue, and skin reactions.

Furate Nasal Spray is a combination of Fluticasone Propionate and Fluticasone Furoate, designed to provide powerful relief from nasal allergy symptoms and inflammation. Both Fluticasone Propionate and Furoate are corticosteroids that work by reducing inflammation in the nasal passages, effectively alleviating symptoms like nasal congestion, sneezing, runny nose, and itching. These active ingredients inhibit the body\'s immune response to allergens, providing long-lasting relief from conditions such as allergic rhinitis and non-allergic nasal inflammation.The dual formulation enhances the anti-inflammatory effect, ensuring comprehensive management of both mild and severe allergic symptoms. Furate Nasal Spray is ideal for individuals who suffer from persistent or seasonal allergies, offering a fast-acting solution that reduces discomfort and improves breathing. Its targeted nasal delivery ensures that the medication works directly where it\'s needed, providing consistent and reliable relief throughout the day.

SALFLO, is a medication commonly used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other conditions involving reversible airway obstruction. It is a beta-2 adrenergic agonist that works by relaxing the muscles of the airways, making it easier to breathe. SALFLO is typically used in the form of inhalers, nebulizer solutions, or oral tablets, depending on the patient's needs

SALFLO contains Salbutamol 2.5mg, a fast-acting bronchodilator that is widely used to provide relief from bronchospasm and breathing difficulties associated with conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.

Salbutamol works by relaxing the muscles in the airways, which helps to open up the air passages and make breathing easier. It is particularly effective in relieving symptoms such as wheezing, shortness of breath, and chest tightness, providing rapid relief during asthma attacks or episodes of bronchospasm.

KEYHALER DEVICE is a state-of-the-art Dry Powder Inhaler (DPI) designed to deliver medications effectively for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This compact and user-friendly device ensures precise dosing of dry powder formulations, offering consistent and efficient drug delivery directly to the lungs. The KEYHALER DEVICE is engineered for ease of use, making it suitable for patients of all ages, including those with limited inhalation strength.

BUDEFLO 400 contains a combination of Budesonide (400mcg) and Formoterol (6 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

KEYHALER DEVICE is a state-of-the-art Dry Powder Inhaler (DPI) designed to deliver medications effectively for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This compact and user-friendly device ensures precise dosing of dry powder formulations, offering consistent and efficient drug delivery directly to the lungs. The KEYHALER DEVICE is engineered for ease of use, making it suitable for patients of all ages, including those with limited inhalation strength.

KEYHALER DEVICE is a state-of-the-art Dry Powder Inhaler (DPI) designed to deliver medications effectively for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This compact and user-friendly device ensures precise dosing of dry powder formulations, offering consistent and efficient drug delivery directly to the lungs. The KEYHALER DEVICE is engineered for ease of use, making it suitable for patients of all ages, including those with limited inhalation strength.

KEYPACE Valved Spacer: Precision and Efficiency in Inhalation Therapy

The KEYPACE Valved Spacer is an advanced device designed for use with Metered-Dose Inhalers (MDIs) to enhance the effectiveness of inhalation therapy. This spacer ensures precise delivery of medication by reducing the speed of aerosolized particles, allowing more of the drug to reach the lungs while minimizing deposition in the mouth and throat. 

KEYHALER PLUS: Advanced Dry Powder Inhaler for Efficient Respiratory Care

The KEYHALER PLUS is a cutting-edge Dry Powder Inhaler (DPI) device with a 4-pin SS mechanism designed to deliver precise and consistent doses of medication for asthma and chronic obstructive pulmonary disease (COPD). Its robust stainless steel pin system ensures optimal drug dispersion, providing efficient lung deposition for enhanced therapeutic effects.

KEYHALER PLUS: Advanced Dry Powder Inhaler for Efficient Respiratory Care

The KEYHALER PLUS is a cutting-edge Dry Powder Inhaler (DPI) device with a 4-pin SS mechanism designed to deliver precise and consistent doses of medication for asthma and chronic obstructive pulmonary disease (COPD). Its robust stainless steel pin system ensures optimal drug dispersion, providing efficient lung deposition for enhanced therapeutic effects. 

KEYHALER DEVICE is a state-of-the-art Dry Powder Inhaler (DPI) designed to deliver medications effectively for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This compact and user-friendly device ensures precise dosing of dry powder formulations, offering consistent and efficient drug delivery directly to the lungs. The KEYHALER DEVICE is engineered for ease of use, making it suitable for patients of all ages, including those with limited inhalation strength.

KEYHALER DEVICE is a state-of-the-art Dry Powder Inhaler (DPI) designed to deliver medications effectively for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This compact and user-friendly device ensures precise dosing of dry powder formulations, offering consistent and efficient drug delivery directly to the lungs. The KEYHALER DEVICE is engineered for ease of use, making it suitable for patients of all ages, including those with limited inhalation strength.

KEYMASK: The Ideal Accessory for Enhanced Inhalation Therapy

KEYMASK, designed for use with the Keypace Valved Spacer, is a high-quality mask that ensures effective and comfortable drug delivery for patients undergoing inhalation therapy.

BUDEFLO 400 contains a combination of Budesonide (400mcg) and Formoterol (6 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

BUDEFLO-Gthe therapeutic benefits of Glycopyrrolate, Formoterol, and Budesonide to offer an advanced treatment option for respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

BUDEFLO 400 Keyhaler: Advanced Dual Therapy for Severe Respiratory Conditions

BUDEFLO 400 Keyhaler is a powerful combination of Budesonide I.P. 400 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, specifically designed for the effective management of asthma and severe chronic obstructive pulmonary disease (COPD). Budesonide, a high-dose inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and lowers the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), delivers rapid and sustained bronchodilation, ensuring quick relief from bronchospasms and improved airflow. 

Luckys Pharma Lab Pvt. One of the most prominent pharmaceutical company, providing franchise for nephrology products all over India is LIFE LONG PHARMACEUTICALS PVT. Our focus is dedicated to medicines that safeguard kidney health, manage chronic kidney disease (CKD) and its complications, support dialysis care, and maintain electrolyte balance for effective treatment outcomes. Nephrology PCD is a monopoly rights franchise with competitive pricing and WHO-GMP-certified products. Lucky Pharma Lab Pvt.

BUDEFLO-G FORTE: Triple Therapy for Enhanced Respiratory Care

BUDEFLO-G FORTE, delivered through an advanced Keyhaler device, combines Glycopyrrolate 25 mcg, Formoterol 12 mcg, and Budesonide 400 mcg to provide superior management of severe asthma and chronic obstructive pulmonary disease (COPD). Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA), reducing airway constriction and improving airflow. Formoterol, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, offering quick relief from breathing difficulties. Budesonide, a powerful inhaled corticosteroid (ICS), reduces airway inflammation and prevents exacerbations. 

SALFLO contains Salbutamol 2.5mg, a fast-acting bronchodilator that is widely used to provide relief from bronchospasm and breathing difficulties associated with conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.

Salbutamol works by relaxing the muscles in the airways, which helps to open up the air passages and make breathing easier. It is particularly effective in relieving symptoms such as wheezing, shortness of breath, and chest tightness, providing rapid relief during asthma attacks or episodes of bronchospasm.

FYBRO-200 Tablet, containing Pirfenidone 200 mg in an effervescent tablet form, is a specialized treatment for idiopathic pulmonary fibrosis (IPF). Pirfenidone is an antifibrotic and anti-inflammatory agent that helps slow disease progression by reducing lung scarring and inflammation. The effervescent formulation ensures rapid dissolution and absorption, offering convenience and enhanced bioavailability. 

BUDEFLO 400 contains a combination of Budesonide (400mcg) and Formoterol (6 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). 

FLOMATE 250: Effective Dual Therapy for Asthma and COPDFLOMATE 250 combines Fluticasone Propionate I.P. 250 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a comprehensive solution for managing asthma and chronic obstructive pulmonary disease (COPD).

Flomate 250 Keyhaler contains Fluticasone Propionate I.P. 250 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, a combination medication designed for the management of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).

Introduction

Flomate 250 Inhaler is a medication prescribed for the treatment of asthma and chronic obstructive pulmonary disorder (COPD). It works by relaxing the muscles of the airways, thereby widening them and alleviating symptoms such as chest tightness, shortness of breath, wheezing, and coughing. It is important to use this inhaler regularly as directed by your doctor for effective management of asthma and COPD.

Uses

Flomate 250 Inhaler is primarily used in the treatment of chronic obstructive pulmonary disease (COPD).

Benefits

COPD is a group of lung diseases characterized by breathing difficulties, often caused by inflammation and swelling of the airways. Flomate 250 Inhaler helps by:

• Relaxing the muscles of the airways, which widens them and facilitates easier breathing.
• Providing relief from symptoms such as chest tightness, shortness of breath, wheezing, and coughing.
• It is important to avoid smoking and minimize exposure to pollution, dust, and fumes, as these can exacerbate symptoms of COPD. Regular exercise can also help improve lung function and overall strength.

Budesonide I.P. 200 mcg + Formoterol Fumarate Dihydrate I.P. 6 mcg, marketed under the brand name BUDEFLO 200 Dose Counter, is a combination medication used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Budesonide is a corticosteroid that works by reducing inflammation in the airways, thereby decreasing the frequency and severity of asthma attacks or COPD exacerbations. Formoterol Fumarate Dihydrate is a long-acting beta agonist (LABA) that helps to relax the muscles in the airways, making it easier to breathe. This combination medication is typically prescribed for patients who require both an inhaled corticosteroid and a long-acting bronchodilator to manage their respiratory symptoms. The dose is administered via an inhaler equipped with a dose counter, which helps patients track the number of doses remaining in the inhaler and ensures they receive the correct dosage. It is important for patients to use BUDEFLO 200 Dose Counter regularly as prescribed by their healthcare provider to maintain optimal asthma or COPD control and to seek medical advice if their symptoms worsen despite treatment.

Flomate 250 Inhaler presents a powerful combination of fluticasone and formoterol fumarate in a convenient inhalation format, specifically formulated to manage asthma and chronic obstructive pulmonary disease (COPD) effectively. Fluticasone, a corticosteroid, works by reducing inflammation in the airways, thereby preventing asthma symptoms and COPD exacerbations. Formoterol fumarate, a long-acting beta agonist (LABA), complements this action by relaxing the muscles around the airways, facilitating improved airflow and breathing capacity. The inhaler device ensures precise delivery of the medication directly to the lungs, optimizing therapeutic efficacy while minimizing systemic side effects. Flomate 250 Inhaler is designed to provide long-lasting symptom relief, improve lung function, and enhance the overall quality of life for individuals managing respiratory conditions.

Tropium LS is a specialized rotacap formulation that combines levosalbutamol sulphate and ipratropium bromide, tailored for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. This combination medication leverages the synergistic effects of its two active components to provide comprehensive bronchodilation and respiratory relief.

Levosalbutamol Sulphate: Levosalbutamol, a selective beta-2 adrenergic agonist, acts rapidly to relax bronchial smooth muscles. By stimulating beta-2 receptors, levosalbutamol promotes the dilation of the airways, offering quick relief from acute bronchospasm, reducing symptoms like wheezing, shortness of breath, and chest tightness.

Ipratropium Bromide: Ipratropium is an anticholinergic agent that works by blocking muscarinic receptors in the bronchial smooth muscle. This inhibition prevents acetylcholine from binding to these receptors, thereby preventing bronchoconstriction. The result is sustained bronchodilation, helping to keep the airways open for longer periods and improving overall airflow and respiratory function.

Benefits of Tropium LS:

• Dual Mechanism for Enhanced Relief: The combination of a fast-acting beta-2 agonist with a long-acting anticholinergic provides both immediate and sustained bronchodilation, ensuring rapid symptom relief and prolonged control of airway constriction.
• Improved Lung Function: Tropium LS effectively reduces symptoms of COPD and asthma, such as wheezing, breathlessness, and coughing, leading to improved respiratory function and a better quality of life for patients.
• Ease of Use: Designed for use with a Rotahaler device, Tropium LS rotacaps deliver the medication directly to the lungs, ensuring efficient absorption and maximum therapeutic benefit. This delivery method is user-friendly and particularly beneficial for patients who find traditional inhalers challenging to use.